Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
H&D Wireless Sweden Holding B | HDWB | Mar 18, 2024 | 0.02 | +4.05 |
H&M B | HMB | Mar 18, 2024 | 145.76 | -0.10 |
HAKI Safety A | HAKIA | Mar 18, 2024 | 25.40 | 0.00 |
HAKI Safety B | HAKIB | Mar 18, 2024 | 24.20 | 0.00 |
Hamlet BioPharma AB (publ) | HAMLETB | Mar 18, 2024 | 2.04 | -0.97 |
Hansa Biopharma | HNSA | Mar 18, 2024 | 28.36 | -0.70 |
Hanza AB | HANZA | Mar 18, 2024 | 62.80 | +0.64 |
Harm Reduction Group | NOHARM | Mar 18, 2024 | 0.17 | -4.21 |
Havsfrun Investment | HAVS | Mar 18, 2024 | 14.66 | -0.81 |
Havsfrun Investment B | HAVB | Mar 18, 2024 | 14.66 | -0.81 |
Haypp Group | HAYPP | Mar 18, 2024 | 81.60 | -0.24 |
Headsent | VIMAB | Mar 18, 2024 | 9.88 | -5.00 |
Heba B | HEBAB | Mar 18, 2024 | 33.10 | -1.49 |
Hedera Group | HEGR | Mar 18, 2024 | 5.60 | +1.82 |
Heimstaden Pref | HEIMPREF | Mar 18, 2024 | 9.27 | +0.76 |
Heliospectra | HELIO | Mar 18, 2024 | 0.37 | +11.45 |
Hemnet Group | HEM | Mar 18, 2024 | 319.20 | +0.82 |
Hemply Balance | HMPLY | Mar 18, 2024 | 0.04 | +5.41 |
Hexagon B | HEXAB | Mar 18, 2024 | 124.45 | -0.84 |
Hexagon Purus | HPURO | Mar 18, 2024 | 5.93 | -0.50 |
Hexatronic Group | HTRO | Mar 18, 2024 | 26.27 | -2.12 |
Hexicon | HEXI | Mar 18, 2024 | 0.48 | -1.74 |
Hexpol B | HPOLB | Mar 18, 2024 | 126.70 | +0.64 |
Hifab B | HIFAB | Mar 18, 2024 | 2.36 | +0.85 |
High Coast Distillery B | HIGHCOB | Mar 18, 2024 | 42.90 | +0.47 |
Hilbert | HILBB | Mar 18, 2024 | 4.02 | +0.50 |
HMS Networks | HMS | Mar 18, 2024 | 440.20 | -2.95 |
Hoegh Autoliners ASA | HAUTOO | Mar 18, 2024 | 97.25 | -1.07 |
Hoi Publishing AB | HOIB | Mar 18, 2024 | 0.41 | +0.74 |
Hoist Finance | HOFI | Mar 18, 2024 | 47.40 | -1.25 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.